Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic
Identifieur interne : 001F20 ( Ncbi/Curation ); précédent : 001F19; suivant : 001F21Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic
Auteurs : David M. Morens [États-Unis] ; Jeffery K. Taubenberger [États-Unis]Source :
- The Journal of Infectious Diseases [ 0022-1899 ] ; 2019.
Descripteurs français
- KwdFr :
- Adulte, Animaux, Anticorps antiviraux (immunologie), Antigènes viraux (génétique), Antigènes viraux (immunologie), Comportement de recherche d'hôte, Dérive génétique, Enfant d'âge préscolaire, Glycoprotéine hémagglutinine du virus influenza (génétique), Glycoprotéine hémagglutinine du virus influenza (immunologie), Grippe humaine (), Grippe humaine (histoire), Grippe humaine (épidémiologie), Histoire du 20ème siècle, Humains, Infections à Orthomyxoviridae (virologie), Jeune adulte, Pandémies (), Pandémies (histoire), Pneumopathie bactérienne (mortalité), Pneumopathie bactérienne (étiologie), Prédisposition génétique à une maladie, Sialidase (génétique), Sialidase (immunologie), Sous-type H1N1 du virus de la grippe A (génétique), Sous-type H1N1 du virus de la grippe A (immunologie), Suidae (virologie), Sujet âgé, Sujet âgé de 80 ans ou plus, Vaccins antigrippaux (immunologie), Épitopes (immunologie).
- MESH :
- génétique : Antigènes viraux, Glycoprotéine hémagglutinine du virus influenza, Sialidase, Sous-type H1N1 du virus de la grippe A.
- histoire : Grippe humaine, Pandémies.
- immunologie : Anticorps antiviraux, Antigènes viraux, Glycoprotéine hémagglutinine du virus influenza, Sialidase, Sous-type H1N1 du virus de la grippe A, Vaccins antigrippaux, Épitopes.
- mortalité : Pneumopathie bactérienne.
- virologie : Infections à Orthomyxoviridae, Suidae.
- épidémiologie : Grippe humaine.
- étiologie : Pneumopathie bactérienne.
- Adulte, Animaux, Comportement de recherche d'hôte, Dérive génétique, Enfant d'âge préscolaire, Grippe humaine, Histoire du 20ème siècle, Humains, Jeune adulte, Pandémies, Prédisposition génétique à une maladie, Sujet âgé, Sujet âgé de 80 ans ou plus.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Animals, Antibodies, Viral (immunology), Antigens, Viral (genetics), Antigens, Viral (immunology), Child, Preschool, Epitopes (immunology), Genetic Drift, Genetic Predisposition to Disease, Hemagglutinin Glycoproteins, Influenza Virus (genetics), Hemagglutinin Glycoproteins, Influenza Virus (immunology), History, 20th Century, Host-Seeking Behavior, Humans, Influenza A Virus, H1N1 Subtype (genetics), Influenza A Virus, H1N1 Subtype (immunology), Influenza Vaccines (immunology), Influenza, Human (complications), Influenza, Human (epidemiology), Influenza, Human (history), Influenza, Human (prevention & control), Neuraminidase (genetics), Neuraminidase (immunology), Orthomyxoviridae Infections (virology), Pandemics (history), Pandemics (prevention & control), Pneumonia, Bacterial (etiology), Pneumonia, Bacterial (mortality), Swine (virology), Young Adult.
- MESH :
- chemical , genetics : Antigens, Viral, Hemagglutinin Glycoproteins, Influenza Virus, Neuraminidase.
- chemical , immunology : Antibodies, Viral, Antigens, Viral, Epitopes, Hemagglutinin Glycoproteins, Influenza Virus, Influenza Vaccines, Neuraminidase.
- complications : Influenza, Human.
- epidemiology : Influenza, Human.
- etiology : Pneumonia, Bacterial.
- genetics : Influenza A Virus, H1N1 Subtype.
- history : Influenza, Human, Pandemics.
- immunology : Influenza A Virus, H1N1 Subtype.
- mortality : Pneumonia, Bacterial.
- prevention & control : Influenza, Human, Pandemics.
- virology : Orthomyxoviridae Infections, Swine.
- Adult, Aged, Aged, 80 and over, Animals, Child, Preschool, Genetic Drift, Genetic Predisposition to Disease, History, 20th Century, Host-Seeking Behavior, Humans, Young Adult.
Abstract
The year 2018 marked the 100th anniversary of the deadliest event in human history. In 1918–1919, pandemic influenza spread globally and caused an estimated 50–100 million deaths associated with unexpected clinical and epidemiological features. The descendants of the 1918 virus continue to circulate as annual epidemic viruses causing significant mortality each year. The 1918 influenza pandemic serves as a benchmark for the development of universal influenza vaccines. Challenges to producing a truly universal influenza vaccine include eliciting broad protection against antigenically different influenza viruses that can prevent or significantly downregulate viral replication and reduce morbidity by preventing development of viral and secondary bacterial pneumonia. Perhaps the most important goal of such vaccines is not to prevent influenza, but to prevent influenza deaths.
Url:
DOI: 10.1093/infdis/jiy728
PubMed: 30715352
PubMed Central: 6452324
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000723
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :000723
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000058
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000174
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000174
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000125
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001F20
Links to Exploration step
PMC:6452324Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic</title>
<author><name sortKey="Morens, David M" sort="Morens, David M" uniqKey="Morens D" first="David M" last="Morens">David M. Morens</name>
<affiliation wicri:level="2"><nlm:aff id="AF0001">Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Taubenberger, Jeffery K" sort="Taubenberger, Jeffery K" uniqKey="Taubenberger J" first="Jeffery K" last="Taubenberger">Jeffery K. Taubenberger</name>
<affiliation wicri:level="2"><nlm:aff id="AF0002">Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">30715352</idno>
<idno type="pmc">6452324</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452324</idno>
<idno type="RBID">PMC:6452324</idno>
<idno type="doi">10.1093/infdis/jiy728</idno>
<date when="2019">2019</date>
<idno type="wicri:Area/Pmc/Corpus">000723</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000723</idno>
<idno type="wicri:Area/Pmc/Curation">000723</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000723</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000058</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000058</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:30715352</idno>
<idno type="wicri:Area/PubMed/Corpus">000174</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000174</idno>
<idno type="wicri:Area/PubMed/Curation">000174</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000174</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000125</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000125</idno>
<idno type="wicri:Area/Ncbi/Merge">001F20</idno>
<idno type="wicri:Area/Ncbi/Curation">001F20</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic</title>
<author><name sortKey="Morens, David M" sort="Morens, David M" uniqKey="Morens D" first="David M" last="Morens">David M. Morens</name>
<affiliation wicri:level="2"><nlm:aff id="AF0001">Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Taubenberger, Jeffery K" sort="Taubenberger, Jeffery K" uniqKey="Taubenberger J" first="Jeffery K" last="Taubenberger">Jeffery K. Taubenberger</name>
<affiliation wicri:level="2"><nlm:aff id="AF0002">Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">The Journal of Infectious Diseases</title>
<idno type="ISSN">0022-1899</idno>
<idno type="eISSN">1537-6613</idno>
<imprint><date when="2019">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Animals</term>
<term>Antibodies, Viral (immunology)</term>
<term>Antigens, Viral (genetics)</term>
<term>Antigens, Viral (immunology)</term>
<term>Child, Preschool</term>
<term>Epitopes (immunology)</term>
<term>Genetic Drift</term>
<term>Genetic Predisposition to Disease</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus (genetics)</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus (immunology)</term>
<term>History, 20th Century</term>
<term>Host-Seeking Behavior</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype (genetics)</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (complications)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (history)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Neuraminidase (genetics)</term>
<term>Neuraminidase (immunology)</term>
<term>Orthomyxoviridae Infections (virology)</term>
<term>Pandemics (history)</term>
<term>Pandemics (prevention & control)</term>
<term>Pneumonia, Bacterial (etiology)</term>
<term>Pneumonia, Bacterial (mortality)</term>
<term>Swine (virology)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Animaux</term>
<term>Anticorps antiviraux (immunologie)</term>
<term>Antigènes viraux (génétique)</term>
<term>Antigènes viraux (immunologie)</term>
<term>Comportement de recherche d'hôte</term>
<term>Dérive génétique</term>
<term>Enfant d'âge préscolaire</term>
<term>Glycoprotéine hémagglutinine du virus influenza (génétique)</term>
<term>Glycoprotéine hémagglutinine du virus influenza (immunologie)</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (histoire)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Histoire du 20ème siècle</term>
<term>Humains</term>
<term>Infections à Orthomyxoviridae (virologie)</term>
<term>Jeune adulte</term>
<term>Pandémies ()</term>
<term>Pandémies (histoire)</term>
<term>Pneumopathie bactérienne (mortalité)</term>
<term>Pneumopathie bactérienne (étiologie)</term>
<term>Prédisposition génétique à une maladie</term>
<term>Sialidase (génétique)</term>
<term>Sialidase (immunologie)</term>
<term>Sous-type H1N1 du virus de la grippe A (génétique)</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Suidae (virologie)</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Épitopes (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Antigens, Viral</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus</term>
<term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term>
<term>Antigens, Viral</term>
<term>Epitopes</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus</term>
<term>Influenza Vaccines</term>
<term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Pneumonia, Bacterial</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Antigènes viraux</term>
<term>Glycoprotéine hémagglutinine du virus influenza</term>
<term>Sialidase</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="histoire" xml:lang="fr"><term>Grippe humaine</term>
<term>Pandémies</term>
</keywords>
<keywords scheme="MESH" qualifier="history" xml:lang="en"><term>Influenza, Human</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Antigènes viraux</term>
<term>Glycoprotéine hémagglutinine du virus influenza</term>
<term>Sialidase</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Vaccins antigrippaux</term>
<term>Épitopes</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Pneumonia, Bacterial</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à Orthomyxoviridae</term>
<term>Suidae</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Orthomyxoviridae Infections</term>
<term>Swine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Animals</term>
<term>Child, Preschool</term>
<term>Genetic Drift</term>
<term>Genetic Predisposition to Disease</term>
<term>History, 20th Century</term>
<term>Host-Seeking Behavior</term>
<term>Humans</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Animaux</term>
<term>Comportement de recherche d'hôte</term>
<term>Dérive génétique</term>
<term>Enfant d'âge préscolaire</term>
<term>Grippe humaine</term>
<term>Histoire du 20ème siècle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Pandémies</term>
<term>Prédisposition génétique à une maladie</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><title>Abstract</title>
<p>The year 2018 marked the 100th anniversary of the deadliest event in human history. In 1918–1919, pandemic influenza spread globally and caused an estimated 50–100 million deaths associated with unexpected clinical and epidemiological features. The descendants of the 1918 virus continue to circulate as annual epidemic viruses causing significant mortality each year. The 1918 influenza pandemic serves as a benchmark for the development of universal influenza vaccines. Challenges to producing a truly universal influenza vaccine include eliciting broad protection against antigenically different influenza viruses that can prevent or significantly downregulate viral replication and reduce morbidity by preventing development of viral and secondary bacterial pneumonia. Perhaps the most important goal of such vaccines is not to prevent influenza, but to prevent influenza deaths.</p>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F20 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001F20 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= Ncbi |étape= Curation |type= RBID |clé= PMC:6452324 |texte= Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:30715352" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a PandemieGrippaleV1
This area was generated with Dilib version V0.6.34. |